🇺🇸 FDA
Pipeline program

Neofordex 40 mg tablets, IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM., PREDNISONE

APHP200017

Phase 3 small_molecule active

Quick answer

Neofordex 40 mg tablets, IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM., PREDNISONE for Adult patients with immune thrombocytopenia (ITP) with mild to severe bleeding manifestations is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
Adult patients with immune thrombocytopenia (ITP) with mild to severe bleeding manifestations
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials